global Biological data visualization market stood at $720.1 million in 2025 and is expected to grow to $1,639.8 million by 2035, registering a CAGR of 8.7% from 2026 to 2035. The global generation of biological data has reached unprecedented levels, creating a critical need for platforms that help researchers interpret complex datasets efficiently. Public repositories such as EMBL-EBI and sequence archives like NCBI GenBank reflect a massive accumulation of raw biological information that must be accessed, analyzed, and visualized across genomics, imaging, and multi-omics disciplines. The European Molecular Biology Laboratory’s European Bioinformatics Institute (EMBL-EBI), one of the world’s leading sources of public biomolecular data, recorded over 16 petabytes of new data submissions in 2024, bringing total cumulative data to approximately 123 petabytes. Genomics repositories, including the European Nucleotide Archive (ENA) and the European Genome–phenome Archive (EGA), together account for more than 90 percent of this deposited volume.
Browse the full report description of “Biological Data Visualization Market Size, Share & Trends Analysis Report by Technique (Magnetic Resonance Imaging, Microscopy, Sequencing, and Others), By Application (Genomic Analysis, Cell Biology, Molecular & Structural Analysis, and Others), By End-User (Pharmaceutical & Biotechnology Companies, Research Institutes, Hospitals and Clinics) Forecast Period, (2026-2035)” at https://www.omrglobal.com/industry-reports/biological-data-visualization-market
In parallel, imaging resources are expanding rapidly. Archives such as the BioImage Archive (BIA), Electron Microscopy Public Image Archive (EMPIAR), and Electron Microscopy Databank (EMDB) are experiencing significant growth, reflecting the increasing demand for structured storage and access to large-scale imaging datasets. Meanwhile, NCBI GenBank grew from roughly 31 trillion bases in April 2024 to nearly 39 trillion bases by December 2024, with over 5.36 billion associated records, emphasizing the sheer scale of data requiring visualization for effective analysis. Additionally, Human Cell Atlas (HCA) datasets hosted through the AWS Open Data Program exceed 300 terabytes, illustrating both the size of modern biological data and the infrastructure required for global, interactive visualization.
These rapid increases in genomics, imaging, and multi-omics datasets are directly fueling the Biological Data Visualization market. Advanced visualization tools are now essential for transforming raw biological outputs into interpretable formats, supporting faster discovery, accurate diagnostics, and informed decision-making across research institutes, pharmaceutical and biotechnology companies, and clinical settings. As data volumes continue to grow, the adoption of visualization platforms is expected to accelerate, driving robust market expansion in the coming years.
Market Coverage
Key questions addressed by the report.
Global Biological Data Visualization Market Report Segment
By Technique
By Application
By End-User
Global Biological Data Visualization Market Report Segment by Region
North America
Europe
Asia-Pacific
Rest of the World
To learn more about this report request a sample copy @ https://www.omrglobal.com/request-sample/biological-data-visualization-market